Search

Ebenezer O. Sackey

Examiner (ID: 17838)

Most Active Art Unit
1624
Art Unit(s)
1613, 1201, 1626, 1624, 1621
Total Applications
2086
Issued Applications
1598
Pending Applications
91
Abandoned Applications
399

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 4960639 [patent_doc_number] => 20080275064 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-06 [patent_title] => 'Substituted Pyrimidines as Adenosine Receptor Antagonists' [patent_app_type] => utility [patent_app_number] => 11/911187 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 37229 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0275/20080275064.pdf [firstpage_image] =>[orig_patent_app_number] => 11911187 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/911187
Substituted Pyrimidines as Adenosine Receptor Antagonists Apr 10, 2006 Abandoned
Array ( [id] => 5689020 [patent_doc_number] => 20060287335 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-12-21 [patent_title] => 'Serotonergic agents for treating sexual dysfunction' [patent_app_type] => utility [patent_app_number] => 11/396307 [patent_app_country] => US [patent_app_date] => 2006-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 7793 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20060287335.pdf [firstpage_image] =>[orig_patent_app_number] => 11396307 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/396307
Serotonergic agents for treating sexual dysfunction Mar 29, 2006 Abandoned
Array ( [id] => 5876216 [patent_doc_number] => 20060167299 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-27 [patent_title] => 'Hydrothermally synthesized Mo-V-M-Nb-X oxide catalysts for the selective oxidation of hydrocarbons' [patent_app_type] => utility [patent_app_number] => 11/389940 [patent_app_country] => US [patent_app_date] => 2006-03-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 16389 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0167/20060167299.pdf [firstpage_image] =>[orig_patent_app_number] => 11389940 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/389940
Hydrothermally synthesized Mo-V-M-Nb-X oxide catalysts for the selective oxidation of hydrocarbons Mar 26, 2006 Issued
Array ( [id] => 178089 [patent_doc_number] => 07655798 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-02-02 [patent_title] => 'Process of making crystalline Type II aripiprazole' [patent_app_type] => utility [patent_app_number] => 11/377398 [patent_app_country] => US [patent_app_date] => 2006-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4245 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/655/07655798.pdf [firstpage_image] =>[orig_patent_app_number] => 11377398 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/377398
Process of making crystalline Type II aripiprazole Mar 16, 2006 Issued
Array ( [id] => 63074 [patent_doc_number] => 07763650 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-07-27 [patent_title] => 'Pharmaceutical compound and method' [patent_app_type] => utility [patent_app_number] => 11/375936 [patent_app_country] => US [patent_app_date] => 2006-03-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 4503 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/763/07763650.pdf [firstpage_image] =>[orig_patent_app_number] => 11375936 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/375936
Pharmaceutical compound and method Mar 14, 2006 Issued
Array ( [id] => 5609169 [patent_doc_number] => 20060270685 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Anhydrous ziprasidone mesylate and a process for its preparation' [patent_app_type] => utility [patent_app_number] => 11/376551 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 6990 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 17 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270685.pdf [firstpage_image] =>[orig_patent_app_number] => 11376551 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376551
Anhydrous ziprasidone mesylate and a process for its preparation Mar 13, 2006 Abandoned
Array ( [id] => 5700754 [patent_doc_number] => 20060217439 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-09-28 [patent_title] => 'Stable no-delivering compounds' [patent_app_type] => utility [patent_app_number] => 11/376756 [patent_app_country] => US [patent_app_date] => 2006-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5769 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0217/20060217439.pdf [firstpage_image] =>[orig_patent_app_number] => 11376756 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/376756
Stable no-delivering compounds Mar 13, 2006 Issued
Array ( [id] => 5677455 [patent_doc_number] => 20060182810 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles' [patent_app_type] => utility [patent_app_number] => 11/365625 [patent_app_country] => US [patent_app_date] => 2006-03-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 9934 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0182/20060182810.pdf [firstpage_image] =>[orig_patent_app_number] => 11365625 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/365625
Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles Mar 1, 2006 Abandoned
Array ( [id] => 5410102 [patent_doc_number] => 20090124001 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-05-14 [patent_title] => '9-AMINO-ACRIDINE DERIVATIVES AND THEIR USE FOR ELIMINATING MISFOLDED PROTEINS' [patent_app_type] => utility [patent_app_number] => 11/817622 [patent_app_country] => US [patent_app_date] => 2006-02-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7341 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0124/20090124001.pdf [firstpage_image] =>[orig_patent_app_number] => 11817622 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/817622
9-amino-acridine derivatives and their use for eliminating misfolded proteins Feb 27, 2006 Issued
Array ( [id] => 5632417 [patent_doc_number] => 20060148887 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-07-06 [patent_title] => 'Chemical compounds' [patent_app_type] => utility [patent_app_number] => 11/358601 [patent_app_country] => US [patent_app_date] => 2006-02-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7108 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20060148887.pdf [firstpage_image] =>[orig_patent_app_number] => 11358601 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/358601
Chemical compounds Feb 20, 2006 Abandoned
Array ( [id] => 803336 [patent_doc_number] => 07423040 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-09-09 [patent_title] => 'Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same' [patent_app_type] => utility [patent_app_number] => 11/354652 [patent_app_country] => US [patent_app_date] => 2006-02-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 15 [patent_no_of_words] => 9696 [patent_no_of_claims] => 30 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/423/07423040.pdf [firstpage_image] =>[orig_patent_app_number] => 11354652 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/354652
Stable crystalline form of bifeprunox mesylate, dosage forms thereof and methods for using same Feb 15, 2006 Issued
Array ( [id] => 5609168 [patent_doc_number] => 20060270684 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-11-30 [patent_title] => 'Crystalline forms of ziprasidone mesylate' [patent_app_type] => utility [patent_app_number] => 11/353421 [patent_app_country] => US [patent_app_date] => 2006-02-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 51 [patent_figures_cnt] => 51 [patent_no_of_words] => 13418 [patent_no_of_claims] => 93 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0270/20060270684.pdf [firstpage_image] =>[orig_patent_app_number] => 11353421 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/353421
Crystalline forms of ziprasidone mesylate Feb 12, 2006 Abandoned
Array ( [id] => 4779679 [patent_doc_number] => 20080287677 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2008-11-20 [patent_title] => 'Salts of Aripiprazole' [patent_app_type] => utility [patent_app_number] => 11/883125 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 5669 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0287/20080287677.pdf [firstpage_image] =>[orig_patent_app_number] => 11883125 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/883125
Salts of aripiprazole Jan 26, 2006 Issued
Array ( [id] => 4629596 [patent_doc_number] => 08008490 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-08-30 [patent_title] => 'Polymorphic forms of aripiprazole and method' [patent_app_type] => utility [patent_app_number] => 11/795909 [patent_app_country] => US [patent_app_date] => 2006-01-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 6817 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 40 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/008/08008490.pdf [firstpage_image] =>[orig_patent_app_number] => 11795909 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/795909
Polymorphic forms of aripiprazole and method Jan 26, 2006 Issued
Array ( [id] => 4634518 [patent_doc_number] => 08012969 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2011-09-06 [patent_title] => '11C-labeled benzyl-lactam compounds and their use as imaging agents' [patent_app_type] => utility [patent_app_number] => 11/813779 [patent_app_country] => US [patent_app_date] => 2006-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 7403 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/08/012/08012969.pdf [firstpage_image] =>[orig_patent_app_number] => 11813779 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/813779
11C-labeled benzyl-lactam compounds and their use as imaging agents Jan 10, 2006 Issued
Array ( [id] => 4989621 [patent_doc_number] => 20070155962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-07-05 [patent_title] => 'Process for preparing titanyl phthalocyanine' [patent_app_type] => utility [patent_app_number] => 11/322077 [patent_app_country] => US [patent_app_date] => 2005-12-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6298 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0155/20070155962.pdf [firstpage_image] =>[orig_patent_app_number] => 11322077 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/322077
Process for preparing titanyl phthalocyanine Dec 29, 2005 Abandoned
Array ( [id] => 32929 [patent_doc_number] => 07790761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2010-09-07 [patent_title] => 'Blockade of voltage dependent sodium channels' [patent_app_type] => utility [patent_app_number] => 11/312569 [patent_app_country] => US [patent_app_date] => 2005-12-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 23299 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 50 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/790/07790761.pdf [firstpage_image] =>[orig_patent_app_number] => 11312569 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/312569
Blockade of voltage dependent sodium channels Dec 20, 2005 Issued
Array ( [id] => 5285485 [patent_doc_number] => 20090099160 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2009-04-16 [patent_title] => '4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors' [patent_app_type] => utility [patent_app_number] => 11/793254 [patent_app_country] => US [patent_app_date] => 2005-12-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 31513 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0099/20090099160.pdf [firstpage_image] =>[orig_patent_app_number] => 11793254 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/793254
4-(4-(Imidazol-4-Yl) Pyrimidin-2-Ylamino) Benzamides as CDK Inhibitors Dec 14, 2005 Abandoned
Array ( [id] => 5777580 [patent_doc_number] => 20060106220 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-05-18 [patent_title] => 'Compositions and therapeutic methods involving isoflavones and analogues thereof' [patent_app_type] => utility [patent_app_number] => 11/300976 [patent_app_country] => US [patent_app_date] => 2005-12-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5562 [patent_no_of_claims] => 7 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0106/20060106220.pdf [firstpage_image] =>[orig_patent_app_number] => 11300976 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/300976
Compositions and therapeutic methods involving isoflavones and analogues thereof Dec 13, 2005 Abandoned
Array ( [id] => 917350 [patent_doc_number] => 07323484 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-01-29 [patent_title] => 'Farnesyl transferase inhibitors' [patent_app_type] => utility [patent_app_number] => 11/287996 [patent_app_country] => US [patent_app_date] => 2005-11-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 14376 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/323/07323484.pdf [firstpage_image] =>[orig_patent_app_number] => 11287996 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/287996
Farnesyl transferase inhibitors Nov 27, 2005 Issued
Menu